Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CTLA4(Gene name) > Human
  • Add your favorite
  • CTLA4 (Gene name),
  • Cytotoxic T-lymphocyte protein 4 (Protein name ),  CTLA4_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CTLA4(CD152);
    Protein name:
    Cytotoxic T-lymphocyte protein 4;
    Alternative:
    Cytotoxic T-lymphocyte-associated antigen 4(CTLA-4);
    CD:
    CD152;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Homodimer; disulfide-linked. Binds to CD80/B7-1 and CD86/B7.2.
    Function:
    Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.
    Subcellular Location:
    Cell membrane Single-pass type I membrane protein Exists primarily an intracellular antigen whose surface expression is tightly regulated by restricted trafficking to the cell surface and rapid internalisation;.
    Protein Attributes:
    Sequence length:
    223
    Sequence:
    50:
    MACLGFQRHK | AQLNLATRTW | PCTLLFFLLF | IPVFCKAMHV | AQPAVVLASS | 
    100:
    RGIASFVCEY | ASPGKATEVR | VTVLRQADSQ | VTEVCAATYM | MGNELTFLDD | 
    150:
    SICTGTSSGN | QVNLTIQGLR | AMDTGLYICK | VELMYPPPYY | LGIGNGTQIY | 
    200:
    VIDPEPCPDS | DFLLWILAAV | SSGLFFYSFL | LTAVSLSKML | KKRSPLTTGV | 
    223:
    YVKMPPTEPE | CEKQFQPYFI | PIN
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    SMR:
    KEGG:
    MIM:
    UniGene:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    E1230h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Cytotoxic T-lymphocyte protein 4
    MSDS:
    Please sign in first.
    ELISA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    E1230p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Cytotoxic T-lymphocyte protein 4
    MSDS:
    Please sign in first.
    ELISA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    E1230m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    U1230m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    U1230h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Cytotoxic T-lymphocyte protein 4
    MSDS:
    Please sign in first.
    CLIA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    U1230d
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    U1230p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Polyclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    P1230Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Polyclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Cat.:
    P1230Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Monoclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Monoclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Monoclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Monoclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Monoclonal Antibody for Human Cytotoxic T-lymphocyte protein 4
    Protein for Human Cytotoxic T-lymphocyte protein 4
    Protein for Human Cytotoxic T-lymphocyte protein 4
    Protein for Human Cytotoxic T-lymphocyte protein 4
    Protein for Human Cytotoxic T-lymphocyte protein 4
    Protein for Human Cytotoxic T-lymphocyte protein 4

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location."
      Harper K. , Balzano C. , Rouvier E. , Mattei M.-G. , Luciani M.-F. , Golstein P.
      J. Immunol.147:1037-1044(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1);TISSUE SPECIFICITY;ALTERNATIVE SPLICING;VARIANT ALA-17
    2. 2.
      "Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches."
      Ling V. , Wu P.W. , Finnerty H.F. , Agostino M.J. , Graham J.R. , Chen S. , Jussiff J.M. , Fisk G.J. , Miller C.P. , Collins M.
      Genomics78:155-168(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    3. 3.
      "Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis."
      Gu M. , Kakoulidou M. , Giscombe R. , Pirskanen R. , Lefvert A.K. , Klareskog L. , Wang X.
      Clin. Immunol.128:374-381(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4);VARIANT ALA-17;ALTERNATIVE SPLICING
    4. 4.
      "Full length sequence of hCTLA4 cDNA."
      Wu P.W. , Ling V.
      Submitted (2001-08) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    5. 5.
      NIEHS SNPs program
      Submitted (2006-01) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    6. 6.
      "Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
      Hillier L.W. , Graves T.A. , Fulton R.S. , Fulton L.A. , Pepin K.H. , Minx P. , Wagner-McPherson C. , Layman D. , Wylie K. , Sekhon M. , Becker M.C. , Fewell G.A. , Delehaunty K.D. , Miner T.L. , Nash W.E. , Kremitzki C. , Oddy L. , Du H. , more...
      Nature434:724-731(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Lung.
    8. 8.
      "Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains."
      Dariavach P. , Mattei M.-G. , Golstein P. , Lefranc M.-P.
      Eur. J. Immunol.18:1901-1905(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-223
      tissue: Lymphocyte.
    9. 9.
      Oaks M.K.
      Submitted (1997-02) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 38-223 (ISOFORM 5)
      tissue: Lymph node.
    10. 10.
      "Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders."
      Ling V. , Wu P.W. , Finnerty H.F. , Sharpe A.H. , Gray G.S. , Collins M.
      Genomics60:341-355(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 140-223;TISSUE SPECIFICITY
    11. 11.
      "CTLA-4 is a second receptor for the B cell activation antigen B7."
      Linsley P.S. , Brady W. , Urnes M. , Griosmaire L.S. , Damle N.K. , Ledbetter J.A.
      J. Exp. Med.174:561-569(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    12. 12.
      "Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2."
      Shiratori T. , Miyatake S. , Ohno H. , Nakaseko C. , Isono K. , Bonifacino J.S. , Saito T.
      Immunity6:583-589(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-201
    13. 13.
      "Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4."
      Schneider H. , Schwartzberg P.L. , Rudd C.E.
      Biochem. Biophys. Res. Commun.252:14-19(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-201
    14. 14.
      "Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4."
      Chikuma S. , Murakami M. , Tanaka K. , Uede T.
      J. Cell. Biochem.78:241-250(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT TYR-201 BY JAK2
    15. 16.
      "Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation."
      Darlington P.J. , Kirchhof M.G. , Criado G. , Sondhi J. , Madrenas J.
      J. Immunol.175:996-1004(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-113 AND ASN-145
    16. 17.
      "A molecular perspective of CTLA-4 function."
      Teft W.A. , Kirchhof M.G. , Madrenas J.
      Annu. Rev. Immunol.24:65-97(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;TISSUE SPECIFICITY
    17. 18.
      "CTLA-4 trafficking and surface expression."
      Valk E. , Rudd C.E. , Schneider H.
      Trends Immunol.29:272-279(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION
    18. 19.
      "The clinical utility of inhibiting CD28-mediated costimulation."
      Linsley P.S. , Nadler S.G.
      Immunol. Rev.229:307-321(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHARMACEUTICAL
    19. 20.
      "Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28."
      Metzler W.J. , Bajorath J. , Fenderson W. , Shaw S.Y. , Constantine K.L. , Naemura J. , Leytze G. , Peach R.J. , Lavoie T.B. , Mueller L. , Linsley P.S.
      Nat. Struct. Biol.4:527-531(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 37-165
    20. 21.
      "Structural basis for co-stimulation by the human CTLA-4/B7-2 complex."
      Schwartz J.C. , Zhang X. , Fedorov A.A. , Nathenson S.G. , Almo S.C.
      Nature410:604-608(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 36-161 IN COMPLEX WITH CD86;SUBUNIT;DISULFIDE BONDS
    21. 22.
      "Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses."
      Stamper C.C. , Zhang Y. , Tobin J.F. , Erbe D.V. , Ikemizu S. , Davis S.J. , Stahl M.L. , Seehra J. , Somers W.S. , Mosyak L.
      Nature410:608-611(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 36-161 IN COMPLEX WITH CD80;SUBUNIT;DISULFIDE BONDS;GLYCOSYLATION AT ASN-113 AND ASN-145
    22. 23.
      "Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering."
      Yu C. , Sonnen A.F. , George R. , Dessailly B.H. , Stagg L.J. , Evans E.J. , Orengo C.A. , Stuart D.I. , Ladbury J.E. , Ikemizu S. , Gilbert R.J. , Davis S.J.
      J. Biol. Chem.286:6685-6696(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 36-161;GLYCOSYLATION AT ASN-113;SUBUNIT;DISULFIDE BONDS
    23. 24.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-17;INVOLVEMENT IN IDDM12
    24. 25.
      "CTLA-4 gene polymorphism is associated with predisposition to coeliac disease."
      Djilali-Saiah I. , Schmitz J. , Harfouch-Hammoud E. , Mougenot J.-F. , Bach J.-F. , Caillat-Zucman S.
      Gut43:187-189(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: POLYMORPHISM;INVOLVEMENT IN CELIAC3
    25. 26.
      "Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy."
      Vaidya B. , Imrie H. , Perros P. , Dickinson J. , McCarthy M.I. , Kendall-Taylor P. , Pearce S.H.S.
      Lancet354:743-744(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-17;INVOLVEMENT IN THYROID ASSOCIATED ORBITOPATHY
    26. 27.
      "Complex association analysis of Graves disease using a set of polymorphic markers."
      Chistyakov D.A. , Savost'anov K.V. , Turakulov R.I. , Petunina N.A. , Trukhina L.V. , Kudinova A.V. , Balabolkin M.I. , Nosikov V.V.
      Mol. Genet. Metab.70:214-218(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-17;INVOLVEMENT IN GRAVES DISEASE
    27. 28.
      "Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene."
      Deng Z. , Morse J.H. , Slager S.L. , Cuervo N. , Moore K.J. , Venetos G. , Kalachikov S. , Cayanis E. , Fischer S.G. , Barst R.J. , Hodge S.E. , Knowles J.A.
      Am. J. Hum. Genet.67:737-744(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT ALA-17
    28. 29.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    29. 30.
      "Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection."
      Thio C.L. , Mosbruger T.L. , Kaslow R.A. , Karp C.L. , Strathdee S.A. , Vlahov D. , O'Brien S.J. , Astemborski J. , Thomas D.L.
      J. Virol.78:11258-11262(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO HBV INFECTION;VARIANT ALA-17
    30. 31.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN CELIAC3
    31. 32.
      "CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis."
      Lee Y.H. , Harley J.B. , Nath S.K.
      Hum. Genet.116:361-367(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a KSR2 Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Asprosin TRAP1A Alpha
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter